메뉴 건너뛰기




Volumn 25, Issue 11, 2014, Pages 2173-2178

Prognostic factors for relapse in stage I seminoma: A new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

(21)  Aparicio, J a   Maroto, P b   Garcia del Muro X c   Sanchez Munoz A d   Guma J e   Margeli M f   Saenz A g   Sagastibelza, N h   Castellano, D i   Arranz, J A j   Hervas D k   Bastus R l   Fernandez Aramburo A m   Sastre, J n   Terrasa, J o   Lopez Brea M p   Dorca, J c   Almenar, D q   Carles, J r   Hernandez A s   more..


Author keywords

Adjuvant carboplatin; Prognostic factors; Seminoma; Stage I; Surveillance

Indexed keywords

CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

EID: 84961291043     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu437     Document Type: Article
Times cited : (96)

References (22)
  • 1
    • 33644648880 scopus 로고    scopus 로고
    • Testicular germ-cell cancer
    • Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet 2006; 367: 754-765.
    • (2006) Lancet , vol.367 , pp. 754-765
    • Horwich, A.1    Shipley, J.2    Huddart, R.3
  • 2
    • 73149105939 scopus 로고    scopus 로고
    • Management of stage I seminomatous testicular cancer: a systematic review
    • Chung P, Mayhew LA, Warde P et al. Management of stage I seminomatous testicular cancer: a systematic review. Clin Oncol (R Coll Radiol) 2010; 22: 6-16.
    • (2010) Clin Oncol (R Coll Radiol) , vol.22 , pp. 6-16
    • Chung, P.1    Mayhew, L.A.2    Warde, P.3
  • 3
    • 77954866764 scopus 로고    scopus 로고
    • Management options for stage I seminoma
    • Aparicio J, Díaz R. Management options for stage I seminoma. Expert Rev Anticancer Ther 2010; 10: 1077-1085.
    • (2010) Expert Rev Anticancer Ther , vol.10 , pp. 1077-1085
    • Aparicio, J.1    Díaz, R.2
  • 4
    • 0037112184 scopus 로고    scopus 로고
    • Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis
    • Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 20: 4448-4452.
    • (2002) J Clin Oncol , vol.20 , pp. 4448-4452
    • Warde, P.1    Specht, L.2    Horwich, A.3
  • 5
    • 0038012184 scopus 로고    scopus 로고
    • Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
    • Aparicio J, García del Muro X, Maroto P et al. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 2003; 14: 867-872.
    • (2003) Ann Oncol , vol.14 , pp. 867-872
    • Aparicio, J.1    García del Muro, X.2    Maroto, P.3
  • 6
    • 33644660123 scopus 로고    scopus 로고
    • Risk-adapted management for patients with clinical stage I seminoma: the second Spanish Germ Cell Cancer Group study
    • Aparicio J, Germa JR, García del Muro X et al. Risk-adapted management for patients with clinical stage I seminoma: the second Spanish Germ Cell Cancer Group study. J Clin Oncol 2005; 23: 8717-8723.
    • (2005) J Clin Oncol , vol.23 , pp. 8717-8723
    • Aparicio, J.1    Germa, J.R.2    García del Muro, X.3
  • 7
    • 83355169744 scopus 로고    scopus 로고
    • Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study
    • Aparicio J, Maroto P, García del Muro X et al. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study. J Clin Oncol 2011; 29: 4677-4681.
    • (2011) J Clin Oncol , vol.29 , pp. 4677-4681
    • Aparicio, J.1    Maroto, P.2    García del Muro, X.3
  • 8
    • 84875591927 scopus 로고    scopus 로고
    • Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
    • Beyer J, Albers P, Altena R et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 2013; 24: 878-888.
    • (2013) Ann Oncol , vol.24 , pp. 878-888
    • Beyer, J.1    Albers, P.2    Altena, R.3
  • 9
    • 79952082270 scopus 로고    scopus 로고
    • Prognostic factors for relapse in stage I seminoma managed with surveillance: a validation study
    • Chung PW, Daugaard G, Tydlesley S et al. Prognostic factors for relapse in stage I seminoma managed with surveillance: a validation study. J Clin Oncol 2010; 28 (15s): abstr 4535.
    • (2010) J Clin Oncol , vol.28 , Issue.15
    • Chung, P.W.1    Daugaard, G.2    Tydlesley, S.3
  • 10
    • 79952094417 scopus 로고    scopus 로고
    • Management of seminomatous testicular cancer: a binational prospective population-bases study from the Swedish Norwegian testicular cancer study group
    • Tandstad T, Smaaland R, Solberg A et al. Management of seminomatous testicular cancer: a binational prospective population-bases study from the Swedish Norwegian testicular cancer study group. J Clin Oncol 2011; 29: 719-725.
    • (2011) J Clin Oncol , vol.29 , pp. 719-725
    • Tandstad, T.1    Smaaland, R.2    Solberg, A.3
  • 11
    • 56749175245 scopus 로고    scopus 로고
    • Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study
    • Garcia-del-Muro X, Maroto P, Gumà J et al. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study. J Clin Oncol 2008; 26: 5416-5421.
    • (2008) J Clin Oncol , vol.26 , pp. 5416-5421
    • Garcia-del-Muro, X.1    Maroto, P.2    Gumà, J.3
  • 12
    • 79953324912 scopus 로고    scopus 로고
    • Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
    • Kollmannsberger C, Tyldesley S, Moore C et al. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. Ann Oncol 2011; 22: 808-814.
    • (2011) Ann Oncol , vol.22 , pp. 808-814
    • Kollmannsberger, C.1    Tyldesley, S.2    Moore, C.3
  • 13
    • 84864445837 scopus 로고    scopus 로고
    • Patterns of care in the management of seminoma stage I: results from a European survey
    • Vossen CY, Horwich A, Daugaard G et al. Patterns of care in the management of seminoma stage I: results from a European survey. BJU Int 2012; 110: 524-531.
    • (2012) BJU Int , vol.110 , pp. 524-531
    • Vossen, C.Y.1    Horwich, A.2    Daugaard, G.3
  • 14
    • 84879617192 scopus 로고    scopus 로고
    • Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer
    • Grimison P, Houghton B, Chatfield M et al. Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU Int 2013; 112: E35-E43.
    • (2013) BJU Int , vol.112 , pp. E35-E43
    • Grimison, P.1    Houghton, B.2    Chatfield, M.3
  • 15
    • 84885481001 scopus 로고    scopus 로고
    • A nationwide cohort study of surveillance for stage I seminoma
    • Mortensen MS, Gundgaard MG, Lauritsen J et al. A nationwide cohort study of surveillance for stage I seminoma. J Clin Oncol 2013; 31(suppl); abstr 4502.
    • (2013) J Clin Oncol , vol.31
    • Mortensen, M.S.1    Gundgaard, M.G.2    Lauritsen, J.3
  • 16
    • 77954345456 scopus 로고    scopus 로고
    • Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • Schmoll HJ, Jordan K, Huddart R et al. Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (suppl 5): v140-v146.
    • (2010) Ann Oncol , vol.21 , pp. v140-v146
    • Schmoll, H.J.1    Jordan, K.2    Huddart, R.3
  • 17
    • 79959546636 scopus 로고    scopus 로고
    • EAU guidelines on testicular cancer: 2011 update
    • Albers P, Albrecht W, Algaba F et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304-319.
    • (2011) Eur Urol , vol.60 , pp. 304-319
    • Albers, P.1    Albrecht, W.2    Algaba, F.3
  • 19
    • 79952741548 scopus 로고    scopus 로고
    • Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC30982 Study (ISRCTN27163214)
    • Oliver RTD, Mead GM, Rustin GJS et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC30982 Study (ISRCTN27163214). J Clin Oncol 2011; 29: 957-962.
    • (2011) J Clin Oncol , vol.29 , pp. 957-962
    • Oliver, R.T.D.1    Mead, G.M.2    Rustin, G.J.S.3
  • 20
    • 40149089203 scopus 로고    scopus 로고
    • The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis
    • Powles T, Robinson D, Shamash J et al. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 2008; 19: 443-447.
    • (2008) Ann Oncol , vol.19 , pp. 443-447
    • Powles, T.1    Robinson, D.2    Shamash, J.3
  • 21
    • 84905107175 scopus 로고    scopus 로고
    • Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma; clinical outcomes and prognostic factors for relapse in a large US cohort
    • Soper MS, Hastings JR, Cosmatos HA et al. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma; clinical outcomes and prognostic factors for relapse in a large US cohort. Am J Clin Oncol 2014; 37: 356-359.
    • (2014) Am J Clin Oncol , vol.37 , pp. 356-359
    • Soper, M.S.1    Hastings, J.R.2    Cosmatos, H.A.3
  • 22
    • 78649599450 scopus 로고    scopus 로고
    • Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients
    • Kamba T, Kamoto T, Okubo K et al. Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients. Int J Urol 2010; 17: 980-988.
    • (2010) Int J Urol , vol.17 , pp. 980-988
    • Kamba, T.1    Kamoto, T.2    Okubo, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.